Novan Inc (NASDAQ:NOVN) major shareholder Life Sciences Holdings L. Malin purchased 800,000 shares of the business’s stock in a transaction on Monday, September 26th. The shares were bought at an average cost of $11.00 per share, with a total value of $8,800,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
Shares of Novan Inc (NASDAQ:NOVN) opened at 19.60 on Tuesday. The firm’s 50-day moving average price is $20.77 and its 200 day moving average price is $20.77. Novan Inc has a 12-month low of $13.77 and a 12-month high of $23.79.
Novan Company Profile
Novan, Inc is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its Nitricil technology, which enables the Company to engineer tunable new chemical entities (NCEs).
Receive News & Ratings for Novan Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novan Inc and related companies with MarketBeat.com's FREE daily email newsletter.